3M’s long-anticipated spin-off of its healthcare business group into an independent, publicly-traded Fortune 500 company took a step closer to reality with the filing of a registration statement with the U.S. Securities and Exchange Commission.

Solventum is expected to become its own company on April 1, subject to final approval from the 3M Board of Directors, and has applied to be listed on the New York Stock Exchange as SOLV.

What remains unknown is exactly where the company will land.

3M’s healthcare operations, which had sales of $8.2 billion last year, span more than 20,000 employees throughout 38 countries, including about 1,180 workers in the St. Paul area.

A chief marketing officer for 3M’s healthcare business group indicated last November that no announcements have been made about where Solventum will be based, but she said there were no immediate plans to relocate its 20,000 employees. Company officials had previously said Solventum will remain in Minnesota for at least a couple years during a transition to a new headquarters.

The 313-page “Form 10” registration with the SEC lists the address of Solventum’s principal executive offices as 3M Center on Conway Avenue East in Maplewood.

The company’s principals are Chief Executive Officer Bryan Hanson, Chief Financial Officer Wayde McMillan and Board Chair Carrie Cox.

Solventum plans to host an “investor day” in New York City on March 19, where the leadership team will provide an overview of the business and host a question-and-answer session. A simultaneous webcast and replay of Solventum’s presentation will be available on 3M’s website.